Navigation Links
Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Date:1/13/2009

WHITE PLAINS, N.Y., Jan. 13 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has awarded a $550,000 grant to Anthony Letai, M.D., Ph.D., Department of Medical Oncology at Dana-Farber Cancer Institute in Boston. Millennium: The Takeda Oncology Company of Cambridge, MA provided support to the LLS Career Development Scholar program, which will be used to fund a portion of the five-year research project.

The LLS Scholar in Clinical Research Career Development grant will support Dr. Letai's work on apoptosis, the normal process for eliminating old, unneeded or unhealthy cells. In cancer, this process often is disrupted. Dr. Letai's study, Detecting and Targeting Blocks in Apoptosis in Hematologic Malignancies, is designed to identify the molecules that allow cancer cells to proliferate by inhibiting apoptosis in patients with chronic lymphocytic leukemia, acute lymphoblastic leukemia and diffuse large B-cell lymphoma. His lab has been testing novel targeted therapies that attack these molecules and selectively kill cancer cells.

"I am absolutely delighted to be an LLS Scholar and I appreciate Millennium's support of this important scholarship program," said Dr. Letai. "This grant allows me to be a little more aggressive and take a few more risks that might not otherwise be possible."

LLS's Career Development Program funds talented investigators at different points in their careers: Fellows and Special Fellows during their post-doctoral training years; and Scholars and Scholars in Clinical Research early in their independent academic positions. The program recruits and supports young scientists in blood cancer research, helping populate the field with the best and brightest young researchers who are accomplishing cutting-edge research in established and new laboratories.

"Dr. Letai was selected for this grant because his lab has been applying state-of-the-art scientific techniques and sound scientific principles, and his work has shown great promise in leading to improved treatments for patients with leukemia and lymphoma," said Barton Kamen, M.D., Ph.D., LLS's chief medical officer.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit www.LLS.org or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

    Contact: Andrea Greif
    (914) 821-8958
    andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
2. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
3. UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes
4. Penn researchers unlock molecular origin of blood stem cells
5. McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine
6. Researcher wins $1.2 million grant for gene regulation work
7. McGill researchers discover gene that increases susceptibility to Crohns disease
8. Researchers Gain Insights Into Aging in Mice
9. Researchers discover target that could ease spinal muscular atrophy symptoms
10. Health-monitoring technology helps seniors live at home longer, MU researchers find
11. Old gastrointestinal drug slows aging, McGill researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
Breaking Medicine Technology: